middle.news
Optiscan Unveils InForm™ Pathology Device and Boosts Leadership Amid Strong Cash Position
5:11am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Optiscan Unveils InForm™ Pathology Device and Boosts Leadership Amid Strong Cash Position
5:11am on Monday 2nd of June, 2025 AEST
Key Points
Launch of InForm™ device designed for pathology workflows
Receipt of $1.775 million R&D tax refund, exceeding prior years
Strategic executive appointments including CFO, CCO, and Director of Clinical & Regulatory Affairs
Advancement of telepathology platform to MVP stage and veterinary imaging prototype development
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Optiscan Imaging (ASX:OIL)
OPEN ARTICLE